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- Azure B and its monobrominated derivative were encapsulated in multilamellar liposomes 
- Liposome encapsulation decreased the aggregation of phenothiazine dyes 



















The aim of the present paper was to optimize the properties of phenothiazine photosensitizers (PSs), 
Azure B and its monobrominated derivative.  They were entrapped in multilamellar liposomes of egg 
phosphatidylcholine (EPC) and dipalmitoylphosphatidylcholine (dpPC). The higher partition coefficient 
of both PSs in the EPC/water system compared with that of both PSs in the dpPC/water system allowed 
the selection of EPC to be used for the development of third generation photosensitizers. The optimal 
phospholipid/phenothiazine ratio and the location of these dyes in the lipid bilayer systems were 
established.  These dyes were found to be located within the polar head group region of the lipid bilayer, 
which would enhance the effectiveness of the irradiation procedure. In addition, the encapsulation of 
both photosensitizers in liposomes led to a decrease in the aggregation of these compounds, and 
consequently to an increase in their singlet oxygen quantum yield (). The encapsulation of the PSs in 
lipid vesicles significantly increased their photochemical reactivity, doubling the  value of AzBBr and 
increasing that of AzB by 60%. The results obtained demonstrate that the vehiculization of these PSs in 
liposomes allowed the development of third generation photosensitizers with better photochemical 
properties to be used in potential therapeutic applications.  
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The exposure of Photosensitizers (PSs) to a specific light wavelength induces the production of 
harmful radicals such as reactive species of oxygen (mainly singlet oxygen, 
1
O2) and nitrogen, which are 
capable of killing cells.[1,2] PSs are used in Photodynamic Therapy (PDT) as a valuable alternative for 
the diagnosis and treatment of various types of cancers. It is known as Antimicrobial Photodynamic 
Therapy (APDT) when  it is applied to the treatment of diseases caused by a broad range of species of 
microorganisms, regardless of drug resistance.[3] Both therapies provide a safe and effective way to 
selectively eradicate target cells while avoiding systemic toxicity and side effects on healthy tissues.[4] 
For this reason, PDT and APDT are widely evaluated to address two global issues of health, the 
treatment of cancer and antibiotic resistance, which are a priority for the World Health Organization 
(WHO). Consequently, the development of new PSs and different alternatives to improve the 
effectiveness of these therapies has become an important field of scientific research. 
The clinical use of first and second generation PSs has been questioned because of their low 
selectivity, hydrophobicity, and important biodegradation, among other features. In order to overcome 
these difficulties, different vehiculization strategies are used, which allow obtaining biodegradable 
systems, known as third generation PSs.[5,6] There are different drug delivery approaches that can be 
used for the diagnosis and treatment of numerous diseases Examples of the main nanocarriers used in the 
field of medicine include micelles, liposomes, dendrimers, carbon nanotubes, nanoshells,  and gold, 
silver and copper nanoparticles.[7–15] 
Liposomes are currently one of the most commonly used drug nanocarrier systems in clinical 
applications and are particularly employed in the treatment of various oncological diseases.[16] These 
strategies are widely investigated for their use in PDT and APDT because they are versatile systems 
capable of encapsulating hydrophilic, hydrophobic, and amphiphilic molecules. Liposomes exhibit high 
biocompatibility and increase the amount of PS available at the site of action, preventing its degradation 
and aggregation in the biological environment, as well as reducing unspecific damage.[17–19] In 
addition, numerous studies proved that the use of liposomes for the development of third generation PSs 

















Encouraging results were obtained by using conventional liposomes as nanocarriers for PDT and 
APDT. Visudyne®, a liposomal formulation of verteporfin, is one of the first third generation PSs 
approved by FDA in 2000 for the treatment of age-related macular degeneration. Foslip
®
 is another 
recently developed third generation PS based on a liposomal formulation, which is in preclinical phases. 
[13,14] Several experimental results showed that liposomal formulations exhibit greater photodynamic 
efficiency and cause less damage to healthy tissue. Also, these formulations are less toxic in the absence 
of light compared with the free PS. [15, 16] In conclusion, the encapsulation of different PSs is a 
successful strategy to increase the photoinactivation of bacteria and numerous tumor cells, as well as to 
reduce toxicity and damage to healthy tissue in darkness. 
The purpose of this study was to encapsulate Azure B (AzB) and its novel monobrominated 
derivative (AzBBr) in multilamellar liposomes (MLVs). These vesicular systems were selected to carry 
out biophysical studies and, as a first step, to develop third generation PSs, since they can encapsulate a 
high concentration of lipophilic and amphiphilic drugs, are easy to prepare and are mechanically stable 
during storage.[26,27] In this approach, we evaluated the effect of MLVs on the aggregation of PSs and 
consequently on the production of singlet oxygen. Previous studies have demonstrated that phenothiazine 
dyes form higher order aggregates in aqueous media, which decreases their photodynamic 
efficacy.[28,29] The encapsulation of AzB and AzBBr in liposomes would be an interesting strategy to 

















2 MATERIALS AND METHODS 
2.1 Chemicals 
AzB was purchased from Sigma Aldrich Co. (St. Louis, MO) and used without additional 
purification, while AzBBr was synthesized by the method previously described.[30] Figure S1 (see 
Supporting Information) shows the chemical structure of both compounds, which were used at higher 
purity levels (greater than 95%). 
The lipids, egg-phosphatidylcholine (EPC) and dipalmitoylphosphatidylcholine (dpPC), 
employed for the preparation of liposomes were purchased from Avanti Polar Lipids (Alabaster, 
Alabama) and used without further purification. The fluorescent probes, diphenylhexatriene (DPH), 
trimethyl-ammonium-diphenylhexatriene (TMA-DPH), and 9,10-Anthracenediyl-bis (methylene) 
dimalonic acid (ABDA), were obtained from Sigma Chem. Co (St. Louis, MO). Phosphate-buffered 
saline (PBS, 150 mM pH 7.4) solution was prepared using ultrapure water from a Milli-Q® purification 
system. All reagents and solvents used were of analytical grade. 
 
2.2 Instrumentation 
Absorption spectra were carried out at room temperature with a Cary 60 UV-Vis (Agilent 
Technologies) spectrophotometer between 200 and 800 nm using a 1 cm length quartz cell. 
Fluorescence spectra were recorded on a Fluoromax Spex-3 Jobin Yvon (Horiba, NJ, USA) 
spectrofluorometer equipped with a thermostatized cell, a Xenon arc lamp, and a diode array detector, 
where light intensity was registered by a photon counter system. The excitation and emission slits were 
0.5 nm wide. Excitation wavelength (ex) and emission wavelength (em) were determined for each 
experiment. 
Liposome size and polydispersity index (PI) were determined by dynamic light scattering (DLS) 
at 25 °C using a Beckman Coulter DelsaTM Nano C Particle Analyser with a He-Ne laser (633 nm), a 
scattering angle of 165°, a viscosity of 0.8878 Pa, and a refractive index of 1.3328. The samples were 
appropriately diluted with water before their analysis. A minimum of three measurements were taken and 


















2.3 Preparation of liposomes 
MLVs were prepared by the film-hydration method.[31] Different concentrations of lipids (EPC 
or dpPC) and PSs (AzB or AzBBr) were dissolved in chloroform/methanol (2:1 v/v). The solvents were 
then evaporated under a stream of nitrogen with constant rotation of a test tube so as to deposit a uniform 
film over the bottom third of the tube. Traces of solvents were removed under vacuum. The lipid film 
was rehydrated with PBS by vortexing at a temperature above the gel to liquid-crystalline phase 
transition of the lipids to obtain MLVs. 
 
2.4 Effect of liposome encapsulation on the aggregation properties of photosensitizers 
In order to select the optimal MLVs for the entrapment of the phototherapeutic agents AzB and 
AzBBr, the effect of the encapsulation of these compounds in vesicles of EPC and dpPC on the 
aggregation of PSs was evaluated. MLVs were prepared as mentioned in the previous section using 1 
mg/mL of lipids (EPC or dpPC) and different concentrations of PSs (5-45 M). The resulting samples 
were analyzed by UV-Vis spectrophotometry. The intensity absorption ratio of the two bands 
corresponding to the dimer (𝜆𝑚𝑎𝑥−𝑎𝑏𝑠
𝐴𝑧𝐵 : 646 nm; 𝜆𝑚𝑎𝑥−𝑎𝑏𝑠
𝐴𝑧𝐵𝐵𝑟 : 650 nm) and high aggregates ( 𝜆𝑚𝑎𝑥−𝑎𝑏𝑠
𝐴𝑧𝐵 : 600 
nm; 𝜆𝑚𝑎𝑥−𝑎𝑏𝑠
𝐴𝑧𝐵𝐵𝑟 : 601 nm) was calculated at the  maximum absorption wavelength (max-abs).[28] These 
values were compared with those obtained for AzB and AzBBr in PBS without lipids. The higher values 
of this ratio indicated higher disaggregation of the dyes.[32] 
 
2.5 Optimization of liposomal formulation 
To select the optimal EPC/PS ratio that allows the highest incorporation of the dyes into the 
liposomes, the encapsulation efficiency (EE) of different liposomal preparations was evaluated by UV-
Vis spectrophotometry. Prior to testing EE, it was necessary to select a detergent (DT) to destabilize 
MLVs and subsequently quantify the PSs. 
2.5.1 Selection of detergent for liposome lysis 
The treatment of biomembranes with an excess of DTs produces mixed (DT-phospholipid) 
micelles. This new environment may affect the absorption, excitation, and emission properties of drugs. 
















respectively; em range: 660 - 850 nm) of aqueous solutions of PSs were evaluated in the presence and in 
the absence of different DTs. The effect of anionic (sodium dodecyl sulfate, SDS), cationic (cetyl-
trimethyl-ammoniumbromide, CTAB), and non-ionic (Triton X-100) DTs was tested. Solutions of AzB 
and AzBBr in PBS at different concentrations (1.5 - 20 M) were analyzed. DTs were applied at either 0 
or 35 mM. The higher concentration was well above the critical micelle concentration (cmc) of each 
tested DT.[33] It is important to note that the treatment with SDS could not be processed due to the 
formation of abundant precipitate. 
Absorption spectra were determined between 200 nm and 800 nm at room temperature using a 
quartz cell with an optical path length of 1 cm. Fluorescence spectra were recorded between 660 nm and 
850 nm. The selected ex were the max-abs corresponding to the dimeric species of PSs (646 nm and 650 
nm for AzB and AzBBr, respectively).[28] 
2.5.2 Determination of encapsulation efficiency 
EE was determined as a function of lipid (1 - 30 mg/mL) and PS (36 - 360 M) concentrations 
by UV-Vis spectrophotometry. MLVs of EPC or dpPC were prepared in a final volume of 2 mL. Half of 
the sample volume was used to determine 100% of PS (PStotal). The second half aliquot was centrifuged 
for 15 min at 10000 rpm. Subsequently, the supernatant was separated and the pellet obtained was 
resuspended in 1 mL of PBS. Finally, Triton X-100 (35 mM) was added to the non-centrifuged samples 
(PStotal), supernatants (PSfree), and resuspended pellets (PSencapsulated). The samples were analyzed by UV-
Vis spectrophotometry. The percentage of encapsulated PS was determined by Equations 1 and 2. The 
results obtained were the mean ± SD of both determinations.[34] 
𝑬𝑬 (%) =  
𝑨𝒃𝒔𝑷𝑺 𝒆𝒏𝒄𝒂𝒑𝒔𝒖𝒍𝒂𝒕𝒆𝒅 
𝑨𝒃𝒔𝑷𝑺 𝒕𝒐𝒕𝒂𝒍
 𝒙 𝟏𝟎𝟎%   Equation 1 
𝑬𝑬 (%) =  
𝑨𝒃𝒔𝑷𝑺 𝒕𝒐𝒕𝒂𝒍− 𝑨𝒃𝒔𝑷𝑺 𝒇𝒓𝒆𝒆 
𝑨𝒃𝒔𝑷𝑺 𝒕𝒐𝒕𝒂𝒍
 𝒙 𝟏𝟎𝟎%   Equation 2 
Note that the concentration of AzBBr charged in MLVs was calculated using a molar 






, previously defined in a Triton X-100/EPC 
















2.6 Interaction photosensitizer–multilamellar vesicles 
2.6.1 Evaluation of membrane-water partition coefficient 
Due to the amphiphilic characteristics of AzB and AzBBr, the membrane-water partition 
coefficients (Kp) of these PSs were evaluated. 
The values of Kp were estimated according to the method described by Lissi et al.[35] The 
methodology used is based on the evaluation of a property that depends on the degree of partition of the 
dye. It is a simple method, suitable for the use of spectroscopic techniques and does not require the 
separation of membrane from aqueous solution phases. For the determination of Kp, it is assumed that the 
magnitude of the observed effect is determined only by the concentration of the solute in the 
membrane.[35] 
These tests  involved the spectrophotometric evaluation of the aggregation of PSs (effect that 
depends on the extent of partitioning into the lipid interface), as a function of the dye concentration (8 - 
46 M) at different membrane volumes (VM: 0 - 1 L of EPC) and at a constant volume of the aqueous 





) as a function of the moles of PSs were determined for different EPC 
volumes (Scheme 1). The reciprocal of the slopes obtained (1/S1) was plotted as a function of the VM 
(Scheme 2). The values of Kp were determined from the slopes (S2) and y-intercepts (Y2) corresponding 





    vs    PS moles                           S1                        Scheme 1 
1/ S1   vs    VM                             S2 and Y2                        Scheme 2 
𝑲𝒑 =
𝑺𝟐 ×  𝑽𝒘
𝒀𝟐
     Equation 3 
It is important to note that MLVs were prepared as described in Section 2.3. All samples obtained were 
analyzed by UV-Vis spectrophotometry. 
2.6.2 Localization of the photosensitizers in phospholipid bilayer 
The fluorescence resonance energy transfer (FRET) between fluorescent probes and PSs was 
evaluated in the presence and in the absence of liposomes. The probes used were DPH, known to be 
















DPH, which stabilizes its cationic moiety at the polar head group of the phospholipids (surface of the 
lipid bilayer).[36] MLVs were prepared with 0.5 mg/mL of EPC and 80 M of PSs by the methodology 
previously descripted. Then, stock solutions of DPH or TMA-DPH (1.15 - 15 M) were added to the 
liposomal formulation 1 h before the analysis of the samples. Steady state fluorescence spectra were 
recorded from 380 nm to 750 nm, with the emission set at 356 nm. 
In order to corroborate that FRET only occurs when the probes and PSs are bound to MLVs, 
solutions of AzB and AzBBr (80 μM) with different concentrations of DPH or TMA-DPH (1.15 - 15 
μM) were evaluated in PBS without liposomes. 
 
2.7 Singlet oxygen quantum yields 
The 
1
O2 production of the AzB and AzBBr encapsulated in MLVs of EPC was evaluated 
indirectly analyzing ABDA photooxidation by UV-Vis spectrophotometry at different irradiation times. 
[21,37] The results obtained were compared with those previously published for free PSs in aqueous 
solution by employing the same methodology.[29] 
Liposomal samples were prepared using 15 mg/mL of EPC and 260 μM of the phototherapeutic 
agents AzB or AzBBr (see Section 2.3). The MLV suspensions were centrifuged for 15 min at 10000 
rpm in order to separate free from encapsulated PS. The pellets obtained (MLV + PS encapsulated) were 
resuspended in ultrapure water. Before starting the photooxidation test, an aliquot of ABDA aqueous 
solution, enough to reach an absorbance of around 0.3 at 380 nm, was added to the liposomal samples. 
The samples were irradiated for 360 s using a Parathom® LED lamp (5w - OSRAM) and 
analyzed at different times by UV-Vis spectrophotometry using a quartz cell with an optical path length 
of 1 cm. The irradiance intensity at a 5 cm distance was 8.4 mW/cm2. The absorbance values at 380 nm 
were plotted as a function of the irradiation time. The obtained slopes (kobs) allowed the determination of 
the relative singlet oxygen quantum yields () according to Equation 4, where 𝐴𝑏𝑠0
𝑃𝑆 is the absorbance 
of third generation PSs and 𝐴𝑏𝑠0
𝑅𝑒𝑓
is the absorbance of references at the initial time of the assay. The 
values obtained for  were determined using the free forms of AzB and AzBBr as references. All assays 
















In order to corroborate that the oxidation of ABDA occurs only by the action of the 
1
O2 
generated by the excitation of PSs, samples equivalent to those irradiated were analyzed at different 
times and protected from light. Also, the behavior of ABDA against irradiation in the presence of MLVs 





























3 RESULTS AND DISCUSSION 
3.1 Preparation of liposomes 
Dynamic light scattering (DLS) assays confirmed the formation of vesicular systems. The values 
obtained for the particle size of EPC (0.95 μm) and dpPC (1.2 μm) were consistent with the presence of 
MLVs, considering mainly the method used for their preparation. It has been reported that MLVs have a 
size of between 0.5 -10 μm [38], while the film hydration method leads to the formation of 
heterogeneous multilamellar liposomes with an average diameter of 1-5 μm.[39] Moreover, the 
polydispersion index (PI = 0.3) determined for both samples showed their quite homogeneous particle 
size distribution. In conclusion, the methodology used allowed the obtainment of appropriate liposomal 
preparations for the development of novel third generation PSs. 
 
3.2 Effect of liposome encapsulation on the aggregation properties of photosensitizers 




) as a function of the 
PS concentration for AzB and AzBBr, both free and encapsulated in MLV of EPC and dpPC, are shown 
in Figure 1. 
Figure 1: Evaluation of aggregation of AzB and AzBBr, free and encapsulated in MLVs of EPC (A and 
B) or dpPC (C and D). 
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The trends of the aggregation curves of AzB in aqueous solution and trapped in liposomes differed 
from one another (Figures 1A and 1C). While the free PS exhibited an exponential behavior, the 
entrapped dye showed a sigmoidal decay. However, there was no significant difference in the 
aggregation of AzB encapsulated in MLV of EPC or dpPC over the concentration range evaluated. The 
monobrominated derivative, in contrast, showed an exponential decay for both free and encapsulated PS 





 indicated a predominance of the dimeric form over higher order aggregates, which 
means a decrease in the aggregation and stabilization of the active species of these compounds.[29,40] In 
summary, the aggregation of the encapsulated AzBBr decreased compared with that of the free PS at the 
higher concentrations tested. In addition, the EPC vesicles were more efficient than those of dpPC at 
preventing the aggregation of PSs. This behavior suggests that AzBBr has a greater tendency to partition 
into the EPC liposomes compared with those composed of dpPC due to the lower molecular packing of 
the former at the assayed temperature. Considering that the gel-to-liquid crystalline transition 
temperature is below 0°C and 41.5°C for EPC and DPPC, respectively, it can be predicted that the 
preference of PSs for partitioning in EPC over DPPC will remain in physiological conditions. The higher 
partitioning of PS also explains why EPC is more efficient at preventing the formation of higher order 
aggregates. For this reason, EPC-MLVs were selected to develop the third generation PSs. 
 
3.3 Optimization of liposomal formulation 
3.3.1 Selection of detergent for liposome lysis 
 The absorption spectra of the phototherapeutic agents AzB and AzBBr were determined in PBS 
in the absence and in the presence of CTAB and Triton X-100 (see Figure S2 in Supporting Information). 
While both detergents induced a decrease in the tendency of PSs to aggregate, mainly in the presence of 
Triton X-100, the formation of higher order aggregates was inhibited and the active species of both PSs 
were stabilized. 
Figure 2 shows the results obtained from the fluorescence studies of the PS in the presence and 
in the absence of the different detergents, using as ex the maximum absorption of the dimeric species of 
















concentrations of both PSs in diluted solutions ( 10 M). However, at higher concentrations, samples 
exhibited a decrease in FI. In addition, the normalized curves at the maximum emission wavelength 
(max-em) showed that the increase in the PS concentration produced a bathochromic shift of the spectral 
curves (Figure 2, inserts). This behavior has been previously reported for phthalocyanine compounds 
and was attributed to a fluorescence reabsorption effect. [41] This behavior is independent of the 
formation of aggregates. 
 
 
Figure 2: Fluorescence intensity (FI) vs. the concentration of AzB (A) and AzBBr (B) in PBS in the 
absence and in the presence of different DTs. Insert: Normalized fluorescence spectra at  max-em at 
different concentrations of PSs. Arrows point to the direction observed with increasing concentration of 
PSs: (a) 1.5 M; (h) 30 M.  
 
To determine the effect of DTs on the aggregation of AzB and AzBBr by fluorescence 
spectroscopy, the FI of the samples at the same concentration of the PSs were compared in the presence 
and in the absence of different DTs. Other researchers have shown that H-aggregates (which exhibit 
hypochromic changes) have no fluorescence and lead to efficient fluorescence quenching of other species 
in solution.[42–44] For this reason, an increase in FI during the test indicated an increase in the 
proportion of the dimeric species and consequently a decrease of the higher order aggregates. As shown 
in Figure 2, both evaluated DTs decreased the aggregation of AzB and its monobrominated derivative, 
which corroborates the results obtained by UV-Vis spectrophotometry. In addition to absorbance 
measurement, the FI data shows that Triton X-100 presented the greatest effect on the stabilization of the 
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dimeric species. A similar behavior of Triton X-100 was described by Camur et al. for phthalocyanines 
in aqueous solutions.[45] 
To conclude, Triton X-100 inhibited the formation of higher order aggregates of phenothiazine 
dyes in aqueous medium, stabilizing the dimeric species of AzB and AzBBr. These results support the 
selection of this DT for the destabilization of MLVs in the subsequent quantification of the PSs under 
study. 
3.3.2 Determination of encapsulation efficiency 
In order to evaluate the effect of the EPC concentration on the EE of AzBBr, MLVs prepared 
from different lipid concentrations (1- 30 mg/mL) were analyzed keeping the PS concentration (36 M) 
constant. As shown in Figure 3A, the incorporation of the monobrominated derivative into the vesicular 
system increased exponentially as a function of the EPC concentration. The maximum EE was 88% at 
phospholipid concentrations  15 mg/mL. 
Figure 3: Encapsulation Efficiency (EE) of AzBBr in EPC MLVs as a function of lipid (A) and AzBBr 
(B) concentrations. Insert: Encapsulated mass of PS vs. the dye concentration used for the preparation of 
MLVs. 
 
While EE decreased exponentially with increasing concentrations of AzBBr in the range of 36 to 
260 μM (Figure 3B), the incorporation of this compound into the vesicular system increased 
considerably, achieving a maximum encapsulation of 7x10
-8
 moles (Figure 3B, insert). 
Therefore, 15 mg/mL EPC and 260 μM AzBBr, which correspond to the maximum values in 
Figures 3A and 3B insert, respectively, were selected as the optimal concentrations to develop the third 
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generation PS. Higher concentrations of lipid and dye in the preparation of MLVs would not significantly 
improve the EE of the system. 
The optimal EPC/PS ratio established for the vehiculization of AzBBr was used to determine the 
EE of AzB. The obtained results indicated that MLVs trapped 8x10
-8
 moles of the commercial 
phenothiazine dye. 
In summary, 15 mg/mL of EPC and 260 M of the monobrominated phototherapeutic agent were 
selected as the optimal conditions to charge this PS and used to determine the amount of AzBBr and AzB 
trapped in the MLVs of EPC. These conditions allowed the encapsulation of 8x10
-8
 moles and 7x10
-8 
moles of AzB and AzBBr, respectively. 
 
3.4 Interaction photosensitizer–multilamellar vesicles 
3.4.1 Evaluation of membrane-water partition coefficient 





 vs PS moles determined at different VM (Scheme 1). This linear behavior allowed the 
determination of the membrane/water partition coefficients of AzB and AzBBr. For this, the reciprocal of 
S1 obtained for each PS was plotted as a function of VM (Scheme 2) to determine the Kp of the 
phenothiazines evaluated using Equation 3 (see Figure S3, Supporting Information). 
The log Kp values obtained for AzB and AzBBr were 2.29 and 2.54, respectively. These results 
indicate that both phototherapeutic agents have a higher affinity for the lipid bilayer membrane than for 
the liposomal aqueous core. It is important to note that bromination increased the membrane partitioning 
of phenothiazine compounds. This result is consistent with the increased lipophilicity observed by 
Montes de Oca et al. for AzBBr compared with AzB in the determination of Log PHPLC.[30] 
 
3.4.2 Localization of photosensitizers in phospholipid bilayer 
Förster energy transfer (FRET) is a probabilistic event based on the radiation-less transfer of 
excitation energy from a donor to an acceptor. FRET depends on the degree of spectral overlap between 
the donor and acceptor. Moreover, because the interaction between the donor and acceptor is a dipole-
dipole interaction, FRET is a distance-and orientation-dependent interaction. The energy transfer occurs 
















The absorption band attributable to the phenothiazine compounds, AzB and AzBBr, presented a 
slight overlap with the emission bands of DPH and TMA-DPH (Figure 4A). These results suggest that 
the transfer of energy between the selected probes (DPH and TMA-DPH) (donors) and PSs (acceptors) 
would be viable if they are located within the Förster’s distance.[47] 
Figure 4: (A) Emission spectra of DPH and TMA-DPH ex= 356 nm) and absorption spectra of PSs. 
(B) Emission spectra of AzBBr excited at two different wavelengths. Insert: Emission spectra extended 
at around 675nm. 
 
The emission spectra of the PSs were determined atex= 356 nm (the same used for exciting 
the probes) and at ex= 426 nm (peak of max-emof the probes). AzBBr (Figure 4B) and AzB (not shown) 
exhibited a significant emission band between 400 nm and 500 nm and a lower intensity peak within a 
wavelength range of 650-700 nm (insert, Figure 4B). Because the former band overlapped with the 
emission region of DPH and TMA-DPH, it was not possible to analyze the decrease in the emission 
intensity of the donors during the energy transfer process. However, the increase in the emission intensity 
of the acceptors (PSs) in the presence of the donors at 679 nm would allow the assessment of the 
localization of the phenothiazine dyes in the liposomal membrane by the FRET experiments. 
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The variation of the FI of AzB and AzBBr encapsulated in the liposomes or free in solution as a 
function of the concentration of DPH and TMA-DPH is depicted in Figure 5. Note that in aqueous 
medium the emission of both PSs remained constant for all the concentrations of the probes evaluated. 
This behavior showed that the distance between the donor and acceptor molecules in PBS (without 
liposomes) did not allow the occurrence of FRET.  In contrast, the samples incorporated in MLVs 
showed an exponential increase in the FI of AzB (Figure 5A) and AzBBr (Figure 5B), indicating that 
the FRET process was developed when the compounds were at an appropriate distance. This effect was 
considerably more intense for both dyes in the presence of TMA-DPH, indicating that the phenothiazine 
dyes were located mainly within the polar head region of the phospholipid bilayer of the evaluated 
liposomes.  
 
Figure 5: Effect of concentrations of probes on the FI of AzB (A) and AzBBr (B) free in solution and 
encapsulated in EPC-MLVs. ex: 356 nm and max-em: 679 nm. 
In conclusion, AzB and AzBBr interacted with the membrane of EPC-MLVs and were preferably 
located on the hydrophilic surface of the lipid bilayer. These results are consistent with the amphiphilic 
character of the phenothiazine dyes whose molecular structures are depicted in Figure S1 in the 
Supporting Information section. 









2.2  TMA-DPH in MLV
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3.5 Singlet oxygen quantum yields 
As shown in Table 1, the phenothiazine dyes charged in EPC-MLVs increased the 
photochemical reactivity of both PSs, doubling the value of free AzBBr and increasing that of AzB by 
60%. These results can be associated with the decrease in the aggregation of the phototherapeutic agents, 
mainly of the monobrominated derivative, as a consequence of the entrapment in the liposomal system 
(Section 3.2). It is important to remember that the incorporation of AzBBr in the selected vesicles 
partially reduced the formation of higher aggregates (Figure 1). 
In addition, Figure S4 shows that both irradiated MLVs without photodynamic agents and 
MLVs charged with any of the phenothiazine compounds in the dark did not produce ABDA 
degradation. These results corroborate that the photooxidation of ADBA was caused by the 
1
O2 produced 
after the excitation of the PSs. 
 
 
Consistent with the results obtained in this work, several authors have shown that the 
vehiculization of different PSs in liposomes, micelles and nanoparticles increases the  of these 
compounds. This increase varies from 0.1 to 3.5, depending on the vehiculization system and the PS 
used.[20,29,48,49] 
4 Conclusion 
Multilamellar liposomes of EPC were selected for the development of third generation PSs because 
phenothiazine dyes exhibited a higher partitioning in EPC than in DPPC MLVs. This demonstrates that 
EPC is more efficient at preventing the formation of higher order aggregates. The structural 
Table 1: Singlet oxygen quantum yields of free and encapsulated PSs. 
 
PS Abs0 Slope (x10-3)  
AzB
* 0.16±0.02 1.25±0.03 1.0 
AzB-MLV 0.09±0.01 1.14±0.06 1.6 
AzBBr
* 0.20±0.02 0.96±0.02 1.0 
AzBBr-MLV 0.08±0.01 0.86±0.02 2.2 
















characteristics of AzB and AzBBr favor their location on the hydrophilic surface of the liposomal 
membrane. The phospholipid-PS ratio defined as optimal (15 mg / mL - 260 μM) allowed the 
encapsulation of 8x10
-8
 moles and 7x10
-8
 moles of AzB and AzBBr, respectively. 
In addition, the vehiculization of these phototherapeutic agents in EPC-MLVs proved to be a successful 
strategy to improve the photochemical properties of the second generation PSs. In turn, the increase in 
the  of the encapsulated AzB and AzBBr compared with free PSs can be explained by the decrease in 
the formation of higher aggregates. The 
1
O2 production was enhanced between 60% and 100% as a 
consequence of the PS entrapment in EPC-MLVs. For these reasons, the liposomal systems developed in 
the present work are excellent alternatives to the evaluation of their efficacy in PDT and APDT. Further 
improvements should be made in the composition of these kinds of vectorization systems that tend to 
optimize the photochemical properties of the studied phenothiazine compounds. These strategies should 
be focused on favoring the lipid membrane partitioning of the PSs and/or on increasing the volume of the 
hydrophilic surface of the vectors. 
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Figure 1: Evaluation of aggregation of AzB and AzBBr, free and encapsulated in MLVs of EPC (A and 
B) or dpPC (C and D). 
Figure 2: Fluorescence intensity (FI) vs. the concentration of AzB (A) and AzBBr (B) in PBS in the 
absence and in the presence of different DTs. Insert: Normalized fluorescence spectra at  max-em at 
different concentrations of PSs. Arrows point to the direction observed with increasing concentration of 
PSs: (a) 1.5 M; (h) 30 M.  
Figure 3: Encapsulation Efficiency (EE) of AzBBr in EPC MLVs as a function of lipid (A) and AzBBr 
(B) concentrations. Insert: Encapsulated mass of PS vs. the dye concentration used for the preparation of 
MLVs. 
Figure 4: (A) Emission spectra of DPH and TMA-DPH ex= 356 nm) and absorption spectra of PSs. 
(B) Emission spectra of AzBBr excited at two different wavelengths. Insert: Emission spectra extended 
at around 675nm. 
Figure 5: Effect of concentrations of probes on the FI of AzB (A) and AzBBr (B) free in solution and 
encapsulated in EPC-MLVs. ex: 356 nm and max-em: 679 nm. 
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